Biopharma leaders and pediatric rare disease experts gathered for the FDA's ADEPT 10 workshop to discuss paths to advance neonatal drug development. This is the definitive recap.
B2B medtech marketing materials go sideways when they don't follow FDA principles. Here's 5 ways B2B medtech copy gets risky (and how to fix them).
During the FDA's Digital Health Advisory Committee Meeting, the FDA, clinicians, payers, and developers discussed how generative AI mental health devices can expand access without compromising safety. Here's what happened.
Patient stories are powerful tools to help medical device companies persuade physicians, payers, and patients. Here's why (and how) to tell them. Read the article:
We’re in the final stretch. You might be finalizing budgets, planning for Q1, or checking those last few things off your to-list. You might be gradually winding down or wondering how you’ll get it all done. No …
Sign up to receive our monthly newsletter to get exclusive medtech marketing insights and practical writing tips you can use today. You may occasionally get special updates, but very rarely, I promise.
Sign up to receive our monthly newsletter to get exclusive medtech marketing insights and practical writing tips you can use today. You may occasionally get special updates, but very rarely, I promise.